cash flow should be no problem, DNA should have no problem achieving a net profit of $20+ million dollars this financial year.
This stock is a play on the legal outcome, in Singapore and Cambodia.
Singapore arbitration should be ok.
it is the Cambodia legal case that is iffy, from the strong wording in the annual report. I reckon DNA have more than 50% chance of winning the case in the court of appeal.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
4.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $53.12M | |||
| Open | High | Low | Value | Volume |
| 4.2¢ | 4.3¢ | 4.2¢ | $10.79K | 251.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 2899999 | 4.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.3¢ | 111931 | 1 |
View Market Depth
| Last trade - 15.31pm 11/07/2025 (20 minute delay) ? |
| DNA (ASX) Chart |